Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fraser

Showing results (181-190 of 2,554) with videos related to

Pageof 256
Sort By:
Spine|November 14, 1997
Anterior lumbar interbody fusion. A minimum 10-year follow-upM Penta, R D Fraser
Therapeutic Drug Monitoring|June 19, 1998
Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assayA D Fraser, R Meatherall
Texas Heart Institute Journal|January 1, 1997
One-stage neonatal repair of complex aortic arch obstruction or interruption. Recent experience at Texas Children's HospitalK Hirooka, C D Fraser
The Journal of Thoracic and Cardiovascular Surgery|December 29, 1999
Balloon pump-induced pulsatile perfusion during cardiopulmonary bypass does not improve brain oxygenationA Undar, C D Fraser
Journal of Analytical Toxicology|October 12, 1999
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio studyA D Fraser, D Worth
Journal of Analytical Toxicology|September 1, 1995
Evaluation of the Abbott TDx serum benzodiazepine immunoassay for the analysis of lorazepam, adinazolam, and N-desmethyladinazolamA D Fraser, W Bryan
Journal of Analytical Toxicology|July 1, 1996
Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off valuesA D Fraser, R Meatherall
The International Journal of Artificial Organs|January 23, 1999
Influence of membrane oxygenators on the pulsatile flow in extracorporeal circuits: an experimental analysisA Undar, C D Fraser
Dimensions in Health Service|June 1, 1991
A simplified approach to facility accreditationD Fraser-Simmons, M Colton
Therapeutic Drug Monitoring|November 26, 2003
Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicatorsAlbert D Fraser, Jiri Zamecnik
Pageof 256

Showing results (181-190 of 2,554) with videos related to

Sort By:
Pageof 256
Spine|November 14, 1997
Anterior lumbar interbody fusion. A minimum 10-year follow-upM Penta, R D Fraser
Therapeutic Drug Monitoring|June 19, 1998
Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assayA D Fraser, R Meatherall
Texas Heart Institute Journal|January 1, 1997
One-stage neonatal repair of complex aortic arch obstruction or interruption. Recent experience at Texas Children's HospitalK Hirooka, C D Fraser
The Journal of Thoracic and Cardiovascular Surgery|December 29, 1999
Balloon pump-induced pulsatile perfusion during cardiopulmonary bypass does not improve brain oxygenationA Undar, C D Fraser
Journal of Analytical Toxicology|October 12, 1999
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio studyA D Fraser, D Worth
Journal of Analytical Toxicology|September 1, 1995
Evaluation of the Abbott TDx serum benzodiazepine immunoassay for the analysis of lorazepam, adinazolam, and N-desmethyladinazolamA D Fraser, W Bryan
Journal of Analytical Toxicology|July 1, 1996
Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off valuesA D Fraser, R Meatherall
The International Journal of Artificial Organs|January 23, 1999
Influence of membrane oxygenators on the pulsatile flow in extracorporeal circuits: an experimental analysisA Undar, C D Fraser
Dimensions in Health Service|June 1, 1991
A simplified approach to facility accreditationD Fraser-Simmons, M Colton
Therapeutic Drug Monitoring|November 26, 2003
Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicatorsAlbert D Fraser, Jiri Zamecnik
Pageof 256